These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7701049)

  • 1. Pharmacokinetics and bioavailability of benperidol in schizophrenic patients after intravenous and two different kinds of oral application.
    Seiler W; Wetzel H; Hillert A; Schöllnhammer G; Langer M; Barlage U; Hiemke C
    Psychopharmacology (Berl); 1994 Dec; 116(4):457-63. PubMed ID: 7701049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma levels of benperidol, prolactin, and homovanillic acid after intravenous versus two different kinds of oral application of the neuroleptic in schizophrenic patients.
    Seiler W; Wetzel H; Hillert A; Schöllnhammer G; Benkert O; Hiemke C
    Exp Clin Endocrinol; 1994; 102(4):326-33. PubMed ID: 7813605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol.
    Lintz W; Barth H; Becker R; Frankus E; Schmidt-Böthelt E
    Arzneimittelforschung; 1998 May; 48(5):436-45. PubMed ID: 9638309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 3rd Communication: suppositories.
    Lintz W; Barth H; Osterloh G; Schmidt-Böthelt E
    Arzneimittelforschung; 1998 Sep; 48(9):889-99. PubMed ID: 9793614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of benperidol in volunteers after oral administration.
    Furlanut M; Benetello P; Perosa A; Colombo G; Gallo F; Forgione A
    Int J Clin Pharmacol Res; 1988; 8(1):13-6. PubMed ID: 3366499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of haloperidol and reduced haloperidol in Chinese schizophrenic patients after intravenous and oral administration of haloperidol.
    Chang WH; Lam YW; Jann MW; Chen H
    Psychopharmacology (Berl); 1992; 106(4):517-22. PubMed ID: 1579624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative pharmacokinetics and bioavailability of tapentadol following oral administration of immediate- and prolonged-release formulations.
    Göhler K; Brett M; Smit JW; Rengelshausen J; Terlinden R
    Int J Clin Pharmacol Ther; 2013 Apr; 51(4):338-48. PubMed ID: 23357834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and absolute bioavailability of colchicine after i.v. and oral administration in healthy human volunteers and elderly subjects.
    Rochdi M; Sabouraud A; Girre C; Venet R; Scherrmann JM
    Eur J Clin Pharmacol; 1994; 46(4):351-4. PubMed ID: 7957521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and bioavailability of sulfadiazine and trimethoprim following intravenous, intramuscular and oral administration in ostriches (Struthio camelus).
    Abu-Basha EA; Gehring R; Hantash TM; Al-Shunnaq AF; Idkaidek NM
    J Vet Pharmacol Ther; 2009 Jun; 32(3):258-63. PubMed ID: 19646090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.
    Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L
    Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and bioavailability of doxycycline in ostriches (Struthio camelus) at two different dose rates.
    Abu-Basha EA; Idkaidek NM; Hantash TM
    J Vet Sci; 2006 Dec; 7(4):327-32. PubMed ID: 17106222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and bioavailability of reduced and oxidized N-acetylcysteine.
    Olsson B; Johansson M; Gabrielsson J; Bolme P
    Eur J Clin Pharmacol; 1988; 34(1):77-82. PubMed ID: 3360052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of benperidol and its reduced metabolite in human plasma by high-performance liquid chromatography and electrochemical detection.
    Süss S; Seiler W; Hiemke C; Schöllnhammer G; Wetzel H; Hillert A
    J Chromatogr; 1991 Apr; 565(1-2):363-73. PubMed ID: 1874880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of chlorprothixene after single intravenous and oral administration of three galenic preparations.
    Bagli M; Rao ML; Höflich G; Kasper S; Langer M; Barlage U; Beneke M; Süverkrüp R; Möller HJ
    Arzneimittelforschung; 1996 Mar; 46(3):247-50. PubMed ID: 8901143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elimination half-life and bioavailability of haloperidol in schizophrenic patients.
    Magliozzi JR; Hollister LE
    J Clin Psychiatry; 1985 Jan; 46(1):20-1. PubMed ID: 3965439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of route of administration and feeding schedule on pharmacokinetics of robenacoxib in cats.
    King JN; Jung M; Maurer MP; Schmid VB; Seewald W; Lees P
    Am J Vet Res; 2013 Mar; 74(3):465-72. PubMed ID: 23438125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posaconazole pharmacokinetics after administration of an intravenous solution, oral suspension, and delayed-release tablet to dogs.
    Kendall J; Papich MG
    Am J Vet Res; 2015 May; 76(5):454-9. PubMed ID: 25909378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and bioavailability of oral ergometrine in male volunteers.
    de Groot AN; Vree TB; Hekster YA; van den Biggelaar-Martea M; van Dongen PW; van Roosmalen J
    Biopharm Drug Dispos; 1994 Jan; 15(1):65-73. PubMed ID: 8161717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absolute and relative bioavailability of the HMG-CoA reductase inhibitor cerivastatin.
    Mück W; Ritter W; Ochmann K; Unger S; Ahr G; Wingender W; Kuhlmann J
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):255-60. PubMed ID: 9208342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.